← Evidence map

ReviewDrug safety2016

Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.

Kunihiro YamaokaPubMed ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27193610